# LPIN3

## Overview
The LPIN3 gene encodes the protein lipin 3, which is a member of the lipin family of phosphatidic acid phosphatases. Lipin 3 plays a critical role in lipid metabolism by catalyzing the conversion of phosphatidic acid to diacylglycerol, a key step in the biosynthesis of triacylglycerols and phospholipids. These lipids are vital for energy storage and membrane formation in cells (Temprano2016Redundant; Reue2019Mammalian). The protein is expressed in various tissues, including the small intestine, adipose tissue, and liver, indicating its involvement in lipid metabolic processes across different cell types (Reue2019Mammalian). Lipin 3 contains conserved N-LIP and C-LIP domains, which are characteristic of the lipin family and essential for its enzymatic activity. The gene's expression and function can be modulated by post-translational modifications and alternative splicing, resulting in different isoforms that may have distinct roles in cellular lipid metabolism. Despite some functional redundancy with other lipin proteins, lipin 3 is implicated in early human adipogenesis and lipid biosynthesis, underscoring its importance in maintaining lipid homeostasis (Temprano2016Redundant).

## Structure
The LPIN3 gene encodes a protein involved in lipid metabolism, characterized by a specific molecular structure. The primary structure of the lipin 3 protein consists of a sequence of amino acids that form the basis for its function. Its secondary structure includes alpha helices and beta sheets, which contribute to the protein's stability and folding. The tertiary structure refers to the overall three-dimensional shape of the protein, which is crucial for its biological activity.

Lipin 3 contains conserved domains known as N-LIP and C-LIP, which are essential for its function in lipid metabolism. These domains are characteristic of the lipin family of proteins and play a role in the protein's interactions and enzymatic activity. Post-translational modifications, such as phosphorylation, can occur in lipin 3, potentially affecting its activity and interactions with other molecules.

Splice variants of the LPIN3 gene can lead to different isoforms of the protein, each with distinct functions. These isoforms may vary in their structure and activity, allowing the protein to participate in diverse cellular processes related to lipid metabolism. The presence of these variants highlights the complexity and adaptability of the lipin 3 protein in human physiology.

## Function
Lipin 3, encoded by the LPIN3 gene, is a phosphatidic acid phosphatase involved in lipid metabolism, specifically in the conversion of phosphatidic acid to diacylglycerol. This enzymatic activity is crucial for the biosynthesis of triacylglycerols (TAG) and phospholipids, which are essential for energy storage and membrane formation in cells (Temprano2016Redundant; Reue2019Mammalian). Lipin 3 is expressed in various tissues, including the small intestine, adipose tissue, and liver, suggesting its role in lipid metabolism across different cell types (Reue2019Mammalian).

In the small intestine, lipin 3, along with lipin 2, participates in the reassembly of dietary fatty acids into TAGs within enterocytes. These TAGs are either stored as lipid droplets or incorporated into chylomicron particles for secretion, highlighting lipin 3's role in dietary fat processing (Reue2019Mammalian). In adipocytes, lipin 3 contributes to TAG synthesis, although its role is considered minor compared to lipin 1. The presence of compensatory mechanisms suggests that lipin 3's function may overlap with other lipin family members (Temprano2016Redundant). Despite its seemingly redundant role, lipin 3 is involved in early human adipogenesis, indicating its importance in lipid biosynthesis and adipocyte differentiation (Temprano2016Redundant).

## Clinical Significance
Mutations in the LPIN3 gene have been associated with metabolic disorders, particularly those affecting lipid metabolism. A specific mutation, c.622G > A, p.Glu208Lys, has been identified in a male infant presenting with a complex clinical picture involving neurofibromatosis type 1 and progressive familial intrahepatic cholestasis type 2. This LPIN3 mutation is linked to lipodystrophy, a condition characterized by the loss of body fat, fatty liver, hypertriglyceridemia, and insulin resistance. Although this particular variant had not been previously reported in the Human Gene Mutation Database, in silico analysis suggests it may have a pathogenic effect, indicating its potential role in disrupting normal lipid homeostasis (Altay2020Coexistence).

Alterations in LPIN3 expression or mutations can impact lipid metabolism, potentially contributing to metabolic disorders such as obesity, insulin resistance, and dyslipidemia. The gene's interactions with other metabolic pathways may also influence these conditions, highlighting the complexity of diagnosing and managing diseases involving multiple genetic mutations. The case study underscores the diagnostic challenges posed by the coexistence of multiple genetic mutations, emphasizing the need for comprehensive genetic testing and analysis in similar clinical scenarios (Altay2020Coexistence).


## References


[1. (Altay2020Coexistence) Derya Altay, Orhan Gorukmez, and Duran Arslan. Coexistence of three different mutations in a male infant: neurofibromatosis type 1, progressive familial intrahepatic cholestasis type 2 and lpin3. Fetal and Pediatric Pathology, 41(2):293–298, June 2020. URL: http://dx.doi.org/10.1080/15513815.2020.1783405, doi:10.1080/15513815.2020.1783405. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/15513815.2020.1783405)

[2. (Temprano2016Redundant) Ana Temprano, Hiroshi Sembongi, Gil-Soo Han, David Sebastián, Jordi Capellades, Cristóbal Moreno, Juan Guardiola, Martin Wabitsch, Cristóbal Richart, Oscar Yanes, Antonio Zorzano, George M. Carman, Symeon Siniossoglou, and Merce Miranda. Redundant roles of the phosphatidate phosphatase family in triacylglycerol synthesis in human adipocytes. Diabetologia, 59(9):1985–1994, June 2016. URL: http://dx.doi.org/10.1007/s00125-016-4018-0, doi:10.1007/s00125-016-4018-0. This article has 24 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1007/s00125-016-4018-0)

[3. (Reue2019Mammalian) Karen Reue and Huan Wang. Mammalian lipin phosphatidic acid phosphatases in lipid synthesis and beyond: metabolic and inflammatory disorders. Journal of Lipid Research, 60(4):728–733, April 2019. URL: http://dx.doi.org/10.1194/jlr.s091769, doi:10.1194/jlr.s091769. This article has 47 citations and is from a peer-reviewed journal.](https://doi.org/10.1194/jlr.s091769)